Clinical Trials Browser

Phase 1/2 × HuMax-IL8 × Clear all

NCT03400332 2026-02-24

A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers

Phase 1/2 Completed

281 enrolled 44 charts

Melanoma, Neoplasms

NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

Phase 1/2 Terminated

2 enrolled 11 charts

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

NCT03689699 2025-04-29

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Phase 1/2 Active not recruiting

59 enrolled 9 charts

Prostatic Neoplasms